Skip to main content

Table 1 Clinical characteristics of the reported cases

From: ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature

Case Age Sex Primary site Bone marrow involvement Stage IPI Therapy Survival (Months) Outcome
1 27 M Bone Yes IVB 3 HyperCVAD 11 Alive, with disease
2 41 F Nasal fossa No IA 0 Radiotherapy 13 Alive, NED
3 13 F Cervical LN No IIB 2 LNH96-2002 62 Alive, NED
4 70 M Cervical LN No IIIB 3 CHOP 72 Alive, NED
  1. IPI – International Prognostic Index.
  2. NED – no evidence of disease.
  3. LN – lymph node.
  4. HyperCVAD – hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone alternating with cytarabine and methotrexate.
  5. CHOP – cyclophosphamide, doxorubicin, vincristine, prednisone.